ALIVUS
Alivus Life Sciences Limited
Pharmaceuticals
Share price
₹1,384
Market cap
₹16,984 Cr
1Y return
▲ 49%
A specialized pharmaceutical manufacturer focused on developing and producing high-value active pharmaceutical ingredients for chronic disease treatments across multiple therapeutic areas. Operating as a subsidiary of Nirma Limited, a diversified conglomerate, the company serves global specialty pharmaceutical companies through contract development and manufacturing services. Its distinctive strength lies in producing non-commoditized APIs where technical expertise, regulatory compliance, and quality standards are paramount.
Investors holding Alivus Life Sciences Limited
2.51%
Recent moves 2
ICICI Prudential Mutual FundExited
ICICI Prudential Mutual Fund, which previously held a 1.28 percent stake in Alivus Life Sciences Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.
Read more
Government Pension Fund Global (Norway)Increased
Government Pension Fund Global (Norway) increased its stake in Alivus Life Sciences Limited from 2.34% to 2.40%, growing its shareholding from 2,875,000 to 2,950,000 shares. The value of these additional shares is approximately ₹8.7 crore, based on the company's share price of ₹1160.00.
Read more
Track the whales in Alivus Life Sciences Limited
Get alerted the moment a top investor buys or sells.
Get started